1-2 of 2
Carmen Losada
Close
Sort by
Journal Articles

Single-Agent Ibrutinib As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice in Spain

Pau Abrisqueta Costa, Javier Loscertales, MD, Maria Jose Terol, Angel Ramirez Payer, Macarena Ortiz Pareja, Inmaculada Perez, Carolina Cuellar, Margarita Fernandez De La Mata, Alicia Rodriguez, MD, Ana Lario, Julio Delgado, MD, Ana Cristina Godoy, PhD, Jose M Arguiñano, Maria José Berruezo, Ana C Oliveira, MD PhD, Jose Angel Hernandez-Rivas, MD PhD, María-Dolores García-Malo, MD, Angeles Medina, MD, Paloma García Martín, Santiago Osorio-Prendes, MD, Patricia Baltasar, Miguel Fernandez, MD, Fernando Marco, María-Jesús Vidal, Alicia Susana Smucler Simonovich, Montserrat Lopez Rubio, PhD, Isidro Jarque, Alexia Suárez Cabrera, Ruben Fernandez, MD, Aima Lancharro Anchel, Eduardo Rios Herranz, Carmen Losada, Ernesto Pérez Persona, Ricardo Francisco Garcia, Dr., Rafael Ramos, Lucrecia Yáñez, MD PhD, Jose Luis Bello, MD, Cristina Loriente, Miguel Villanueva
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-136036
Published: 2020
Journal Articles

Profile of Chronic Transfusion-Dependent Patients In Spain (20CH Study)

Raquel de Paz, Ma Carmen Losada Castillo, Matías Díaz Sánchez, Juan García-Talavera, Teresa Pascual García, Teresa Bernal Del Castillo, Rafael Franco Osorio, Pilar Giraldo, Carmen Pedro, Antoni Julià, Andreu Llorente, Ma Luz Martino Galiana, Marta Dueñas Usategui, Manuel Jurado Chacón, Iñigo Romón, Dolores Morales, Concha Zamora De Pedro, Jose Luis Díez, Isabel Sanjuán, Jordi Sierra Gil, Luis Palomera
Journal: Blood
Blood (2010) 116 (21): 4408.
https://doi.org/10.1182/blood.V116.21.4408.4408
Published: 2010